What is Anika Therapeutics Inc's Market Cap?

Anika Therapeutics Inc's Market Cap is $281.6M, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's Enterprise Value?

Anika Therapeutics Inc's Enterprise Value is $243.2M, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's Price / Sales?

Anika Therapeutics Inc's Price / Sales is 2.3×, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's EV / Revenue?

Anika Therapeutics Inc's EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's EV / EBITDA?

Anika Therapeutics Inc's EV / EBITDA is 480.2×, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's Revenue (TTM)?

Anika Therapeutics Inc's Revenue (TTM) is $120.7M, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's Net Income (TTM)?

Anika Therapeutics Inc's Net Income (TTM) is -$3.8M, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's EBITDA?

Anika Therapeutics Inc's EBITDA is $500.0K, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's Diluted EPS (TTM)?

Anika Therapeutics Inc's Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.

What is Anika Therapeutics Inc's EBITDA Margin?

Anika Therapeutics Inc's EBITDA Margin is 0.4%, based on as-reported figures from SEC (XBRL) filings.

Anika Therapeutics Inc (ANIK) Financial Statements

Anika Therapeutics Inc

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG001S609X7

XNAS · usd

21.04▲ 0.23 (1.11%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close20.81

Day's Range20.16 – 21.21

52-Week Range8.37 – 22.88

Volume74.7K

Avg Volume125.4K

Share Statistics

Shares Outstanding

Employees235

ExchangeXNAS

Listed1993-05-03

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Anika Therapeutics Inc (ANIK)

What is Anika Therapeutics Inc's Market Cap?: Anika Therapeutics Inc's Market Cap is $281.6M, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's Enterprise Value?: Anika Therapeutics Inc's Enterprise Value is $243.2M, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's Price / Sales?: Anika Therapeutics Inc's Price / Sales is 2.3×, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's EV / Revenue?: Anika Therapeutics Inc's EV / Revenue is 2.0×, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's EV / EBITDA?: Anika Therapeutics Inc's EV / EBITDA is 480.2×, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's Revenue (TTM)?: Anika Therapeutics Inc's Revenue (TTM) is $120.7M, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's Net Income (TTM)?: Anika Therapeutics Inc's Net Income (TTM) is -$3.8M, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's EBITDA?: Anika Therapeutics Inc's EBITDA is $500.0K, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's Diluted EPS (TTM)?: Anika Therapeutics Inc's Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.
What is Anika Therapeutics Inc's EBITDA Margin?: Anika Therapeutics Inc's EBITDA Margin is 0.4%, based on as-reported figures from SEC (XBRL) filings.